» Articles » PMID: 34809691

STAT Proteins: a Kaleidoscope of Canonical and Non-canonical Functions in Immunity and Cancer

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2021 Nov 23
PMID 34809691
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

STAT proteins represent an important family of evolutionarily conserved transcription factors that play key roles in diverse biological processes, notably including blood and immune cell development and function. Classically, STAT proteins have been viewed as inducible activators of transcription that mediate cellular responses to extracellular signals, particularly cytokines. In this 'canonical' paradigm, latent STAT proteins become tyrosine phosphorylated following receptor activation, typically via downstream JAK proteins, facilitating their dimerization and translocation into the nucleus where they bind to specific sequences in the regulatory region of target genes to activate transcription. However, growing evidence has challenged this paradigm and identified alternate 'non-canonical' functions, such as transcriptional repression and roles outside the nucleus, with both phosphorylated and unphosphorylated STATs involved. This review provides a revised framework for understanding the diverse kaleidoscope of STAT protein functional modalities. It further discusses the implications of this framework for our understanding of STAT proteins in normal blood and immune cell biology and diseases such as cancer, and also provides an evolutionary context to place the origins of these alternative functional modalities.

Citing Articles

STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.

Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B Bioimpacts. 2025; 15:30030.

PMID: 39963570 PMC: 11830145. DOI: 10.34172/bi.30030.


Multi-Omics and Network-Based Drug Repurposing for Septic Cardiomyopathy.

Liu P, Yu X, Pan Q, Ren J, Han Y, Zhang K Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861106 PMC: 11768530. DOI: 10.3390/ph18010043.


Discovery of 2-Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents.

Siddappa T, Ravish A, Xi Z, Mohan A, Girimanchanaika S, Krishnamurthy N ACS Omega. 2025; 10(1):114-126.

PMID: 39829533 PMC: 11740381. DOI: 10.1021/acsomega.3c10504.


The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain.

Haas-Neill L, Meneksedag-Erol D, Chaudhry A, Novoselova M, Ashraf Q, de Araujo E Protein Sci. 2024; 34(1):e70022.

PMID: 39723827 PMC: 11670306. DOI: 10.1002/pro.70022.


Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics.

Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S Int J Mol Sci. 2024; 25(23).

PMID: 39684762 PMC: 11642334. DOI: 10.3390/ijms252313050.


References
1.
Lu R, Zhang Y, Sun J . STAT3 activation in infection and infection-associated cancer. Mol Cell Endocrinol. 2017; 451:80-87. PMC: 5469714. DOI: 10.1016/j.mce.2017.02.023. View

2.
Hixson K, Cogswell M, Brooks-Kayal A, Russek S . Evidence for a non-canonical JAK/STAT signaling pathway in the synthesis of the brain's major ion channels and neurotransmitter receptors. BMC Genomics. 2019; 20(1):677. PMC: 6712773. DOI: 10.1186/s12864-019-6033-2. View

3.
Caldenhoven E, van Dijk T, Solari R, Armstrong J, Raaijmakers J, Lammers J . STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem. 1996; 271(22):13221-7. DOI: 10.1074/jbc.271.22.13221. View

4.
Cui X, Zhang L, Luo J, Rajasekaran A, Hazra S, Cacalano N . Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene. 2007; 26(29):4253-60. DOI: 10.1038/sj.onc.1210222. View

5.
Lim C, Cao X . Structure, function, and regulation of STAT proteins. Mol Biosyst. 2007; 2(11):536-50. DOI: 10.1039/b606246f. View